DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer

F Johannes P van Valenberg,1,* Iris SG Brummelhuis,1,* Lars H Lindner,2 Felix Kuhnle,2 Barbara Wedmann,2 Pascal Schweizer,3 Martin Hossann,3 J Alfred Witjes,1 Egbert Oosterwijk1 1Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands; 2Department of Medicine III, Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	van Valenberg FJP, Brummelhuis ISG, Lindner LH, Kuhnle F, Wedmann B, Schweizer P, Hossann M, Witjes JA, Oosterwijk E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	mibc drug delivery system therapy chemotherapeutic local release porcine model Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/333515a729b14cd1a9a212b945992cbe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:333515a729b14cd1a9a212b945992cbe
record_format	dspace
spelling	oai:doaj.org-article:333515a729b14cd1a9a212b945992cbe2021-12-02T13:36:33ZDPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer1178-2013https://doaj.org/article/333515a729b14cd1a9a212b945992cbe2021-01-01T00:00:00Zhttps://www.dovepress.com/dppg2-based-thermosensitive-liposomes-with-encapsulated-doxorubicin-co-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013F Johannes P van Valenberg,1,* Iris SG Brummelhuis,1,* Lars H Lindner,2 Felix Kuhnle,2 Barbara Wedmann,2 Pascal Schweizer,3 Martin Hossann,3 J Alfred Witjes,1 Egbert Oosterwijk1 1Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands; 2Department of Medicine III, University Hospital LMU Munich, Munich, Germany; 3Thermosome GmbH, Munich, Germany*These authors contributed equally to this workCorrespondence: Iris SG BrummelhuisDepartment of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10 (610), PO Box 9101, Nijmegen 6500 HB, the NetherlandsTel +31 24 3619515Fax +31 24 3635121Email iris.brummelhuis@radboudumc.nlPurpose: Current treatment options for muscle-invasive bladder cancer (MIBC) are associated with substantial morbidity. Local release of doxorubicin (DOX) from phosphatidyldiglycerol-based thermosensitive liposomes (DPPG2-TSL-DOX) potentiated by hyperthermia (HT) in the bladder wall may result in bladder sparing without toxicity of systemic chemotherapy. We investigated whether this approach, compared to conventional DOX application, increases DOX concentrations in the bladder wall while limiting DOX in essential organs.Materials and Methods: Twenty-one pigs were anaesthetized, and a urinary catheter equipped with a radiofrequency-emitting antenna for HT (60 minutes) was placed. Experimental groups consisted of iv low or full dose (20 or 60 mg/m2) DPPG2-TSL-DOX with/without HT, iv low dose (20 mg/m2) free DOX with HT, and full dose (50 mg/50 mL) intravesical DOX with/without HT. After the procedure, animals were immediately sacrificed. HPLC was used to measure DOX levels in the bladder, essential organs and serum, and fluorescence microscopy to evaluate DOX distribution in the bladder wall.Results: Iv DPPG2-TSL-DOX with HT resulted in a significantly higher bladder wall DOX concentration which was more homogeneous distributed, than iv and intravesical free DOX administration with HT. Specifically in the detrusor, DPPG2-TSL-DOX with HT led to a > 7- and 44-fold higher DOX concentration, compared to iv free DOX with HT and intravesical DOX, respectively. Organ DOX concentrations were significantly lower in heart and kidneys, and similar in liver, spleen and lungs, following iv DPPG2-TSL-DOX with HT, compared to iv free DOX. Intravesical DOX led to the lowest organ DOX concentrations.Conclusion: Iv DPPG2-TSL-DOX combined with HT achieved higher DOX concentrations in the bladder wall including the detrusor, compared to conventional iv and intravesical DOX application. In combination with lower DOX accumulation in heart and kidneys, compared to iv free chemotherapy, DPPG2-TSL-DOX with HT has great potential to attain a role as a bladder-sparing treatment for MIBC.Keywords: MIBC, drug delivery system, therapy, chemotherapeutic, local release, porcine modelvan Valenberg FJPBrummelhuis ISGLindner LHKuhnle FWedmann BSchweizer PHossann MWitjes JAOosterwijk EDove Medical Pressarticlemibcdrug delivery systemtherapychemotherapeuticlocal releaseporcine modelMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 75-88 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	mibc drug delivery system therapy chemotherapeutic local release porcine model Medicine (General) R5-920
spellingShingle	mibc drug delivery system therapy chemotherapeutic local release porcine model Medicine (General) R5-920 van Valenberg FJP Brummelhuis ISG Lindner LH Kuhnle F Wedmann B Schweizer P Hossann M Witjes JA Oosterwijk E DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
description	F Johannes P van Valenberg,1,* Iris SG Brummelhuis,1,* Lars H Lindner,2 Felix Kuhnle,2 Barbara Wedmann,2 Pascal Schweizer,3 Martin Hossann,3 J Alfred Witjes,1 Egbert Oosterwijk1 1Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands; 2Department of Medicine III, University Hospital LMU Munich, Munich, Germany; 3Thermosome GmbH, Munich, Germany*These authors contributed equally to this workCorrespondence: Iris SG BrummelhuisDepartment of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10 (610), PO Box 9101, Nijmegen 6500 HB, the NetherlandsTel +31 24 3619515Fax +31 24 3635121Email iris.brummelhuis@radboudumc.nlPurpose: Current treatment options for muscle-invasive bladder cancer (MIBC) are associated with substantial morbidity. Local release of doxorubicin (DOX) from phosphatidyldiglycerol-based thermosensitive liposomes (DPPG2-TSL-DOX) potentiated by hyperthermia (HT) in the bladder wall may result in bladder sparing without toxicity of systemic chemotherapy. We investigated whether this approach, compared to conventional DOX application, increases DOX concentrations in the bladder wall while limiting DOX in essential organs.Materials and Methods: Twenty-one pigs were anaesthetized, and a urinary catheter equipped with a radiofrequency-emitting antenna for HT (60 minutes) was placed. Experimental groups consisted of iv low or full dose (20 or 60 mg/m2) DPPG2-TSL-DOX with/without HT, iv low dose (20 mg/m2) free DOX with HT, and full dose (50 mg/50 mL) intravesical DOX with/without HT. After the procedure, animals were immediately sacrificed. HPLC was used to measure DOX levels in the bladder, essential organs and serum, and fluorescence microscopy to evaluate DOX distribution in the bladder wall.Results: Iv DPPG2-TSL-DOX with HT resulted in a significantly higher bladder wall DOX concentration which was more homogeneous distributed, than iv and intravesical free DOX administration with HT. Specifically in the detrusor, DPPG2-TSL-DOX with HT led to a > 7- and 44-fold higher DOX concentration, compared to iv free DOX with HT and intravesical DOX, respectively. Organ DOX concentrations were significantly lower in heart and kidneys, and similar in liver, spleen and lungs, following iv DPPG2-TSL-DOX with HT, compared to iv free DOX. Intravesical DOX led to the lowest organ DOX concentrations.Conclusion: Iv DPPG2-TSL-DOX combined with HT achieved higher DOX concentrations in the bladder wall including the detrusor, compared to conventional iv and intravesical DOX application. In combination with lower DOX accumulation in heart and kidneys, compared to iv free chemotherapy, DPPG2-TSL-DOX with HT has great potential to attain a role as a bladder-sparing treatment for MIBC.Keywords: MIBC, drug delivery system, therapy, chemotherapeutic, local release, porcine model
format	article
author	van Valenberg FJP Brummelhuis ISG Lindner LH Kuhnle F Wedmann B Schweizer P Hossann M Witjes JA Oosterwijk E
author_facet	van Valenberg FJP Brummelhuis ISG Lindner LH Kuhnle F Wedmann B Schweizer P Hossann M Witjes JA Oosterwijk E
author_sort	van Valenberg FJP
title	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
title_short	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
title_full	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
title_fullStr	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
title_full_unstemmed	DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
title_sort	dppg2-based thermosensitive liposomes with encapsulated doxorubicin combined with hyperthermia lead to higher doxorubicin concentrations in the bladder compared to conventional application in pigs: a rationale for the treatment of muscle-invasive bladder cancer
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/333515a729b14cd1a9a212b945992cbe
work_keys_str_mv	AT vanvalenbergfjp dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT brummelhuisisg dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT lindnerlh dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT kuhnlef dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT wedmannb dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT schweizerp dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT hossannm dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT witjesja dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer AT oosterwijke dppg2basedthermosensitiveliposomeswithencapsulateddoxorubicincombinedwithhyperthermialeadtohigherdoxorubicinconcentrationsinthebladdercomparedtoconventionalapplicationinpigsarationaleforthetreatmentofmuscleinvasivebladdercancer
_version_	1718392665995739136

DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer

Ejemplares similares